C3 Protein (Complement Component 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
C3 Protein (Complement Component 3) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox .infobox .infobox-protein
| protein_name = C3 Protein
| gene = C3
| uniprot_id = P01024
| molecular_weight = ~185 kDa
| localization = Plasma, cytoplasm
| family = Complement system
}}
C3 is a central component of the complement system with roles in innate immunity and neuroinflammation.
- Alpha chain (~110 kDa)
- Beta chain (~70 kDa)
- Multiple disulfide bonds
- Cleavage sites for complement activation
- Complement cascade activation
- Opsonization of pathogens
- Clearance of immune complexes
- Bridging innate and adaptive immunity
- Alzheimer's: C3 activation in AD brain; associated with plaque formation
- MS: Complement-mediated demyelination
- ALS: Activated microglia produce C3
- PD: C3 in Lewy bodies
- Complement inhibitors in development for neuroinflammation
- C3a receptor antagonists
C3 Protein (Complement Component 3) plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of C3 Protein (Complement Component 3) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Morgan BP. Complement in the brain. Molecular Immunology. 2017;89:2-7. PMID:28600937
- Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Trends in Neurosciences. 2011;34(6):333-342. PMID:21429674
- Bonifati DM, Kishore U. Role of complement in neurodegeneration and its therapeutic potential. Frontiers in Immunology. 2020;11:585761. PMID:33362767
- Stevens B, Allen NJ, Vazquez LE, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164-1178. PMID:18083105
- Schafer DP, Lehrman EK, Stevens B. The role of complement in the development of the CNS. Glia. 2013;61(5):687-700. PMID:23468486
- Lakhamum S, Ravishankar P, Shetty D, et al. Role of complement component C3 in neurodegenerative diseases. CNS Neurological Disorders - Drug Targets. 2015;14(9):1186-1194. PMID:26323412
- Zhou J, Yu W, Zhang M, et al. Role of complement activation in Alzheimer's disease. Journal of Molecular Neuroscience. 2021;71(11):2310-2323. PMID:33754287
- Wu T, Dejanovic B, Gandhi M, et al. Complement activation in AD and ALS. Acta Neuropathologica Communications. 2019;7(1):55. PMID:30925932
- [[genes/c3]]
- [[mechanisms/complement-system-pathway]]
- [[mechanisms/neuroinflammation]]